abstract |
The present invention relates to novel 1-benzyl-3-hydroxymethylindazole derivatives according to Formula (I) as described in the claims and to a pharmaceutical composition comprising them, together with a pharmaceutically acceptable vesicle. In addition, the present invention relates to the use of 1-benzyl-3-hydroxymethylindazole derivatives for the preparation of a pharmaceutical composition which is active in the treatment of diseases based on the expression of MCP-1, CX3CR1 and p40, and their use in a method of treatment or prevention of diseases based on the expression of MCP-1, CX3CR1 and p40. |